TNF and Crohn disease: In Crohn’s disease (CD), the combination of anti-tumor necrosis factor-alpha (TNF-α) agents and immunomodulators (IMMs) such as methotrexate (MTX) and azathioprine (AZA) is known to increase instances of complete remission and to prevent recurrence [1].